Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 162 citing articles:

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 307
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
Ainhoa Bilbao, Rainer Spanagel
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 107
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
Corneliu N. Stanciu, Mary F. Brunette, Nikhil Teja, et al.
Psychiatric Services (2021) Vol. 72, Iss. 4, pp. 429-436
Open Access | Times Cited: 60
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 10-30
Open Access | Times Cited: 54
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People
Maximus Berger, Lei Li, Simon Rice, et al.
The Journal of Clinical Psychiatry (2022) Vol. 83, Iss. 5
Open Access | Times Cited: 52
Cannabidiol (CBD) in Cancer Management
Kylie O’Brien
Cancers (2022) Vol. 14, Iss. 4, pp. 885-885
Open Access | Times Cited: 49
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
The therapeutic potential of purified cannabidiol
Saoirse E. O′Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon C. Arnold, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1087-1114
Open Access | Times Cited: 27
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Catalina Christensen, Martin Rose, Claus Cornett, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 25
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 24
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review
Inga Dammann, Cathrin Rohleder, F. Markus Leweke
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 115-132
Closed Access | Times Cited: 13
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature
Kirsten Müller‐Vahl
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 104-114
Open Access | Times Cited: 8
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
Kelly A. Sagar, Staci A. Gruber
CNS Drugs (2025)
Closed Access | Times Cited: 1
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Rafael G. dos Santos, Francisco Silveira Guimarães, José Alexandre S. Crippa, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 6, pp. 517-526
Closed Access | Times Cited: 59
Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
Danielle McCartney, Melissa J. Benson, Ben Desbrow, et al.
Sports Medicine - Open (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 54
The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD
Sukvinder Kaur Bhamra, Ankita Desai, Parmis Imani‐Berendjestanki, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 10, pp. 5734-5740
Closed Access | Times Cited: 49
A scoping review of the use of cannabidiol in psychiatric disorders
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, et al.
Psychiatry Research (2021) Vol. 308, pp. 114347-114347
Open Access | Times Cited: 48
Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study
Toni C. Spinella, Sherry H. Stewart, Julia Naugler, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1965-1977
Open Access | Times Cited: 47
Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey
Kevin F. Boehnke, Joel Gagnier, Lynne Matallana, et al.
Journal of Pain (2021) Vol. 22, Iss. 5, pp. 556-566
Open Access | Times Cited: 46
Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey
Kevin F. Boehnke, Joel Gagnier, Lynne Matallana, et al.
Journal of Pain (2021) Vol. 22, Iss. 11, pp. 1418-1428
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top